Q1 2025 13F Holders as of 31 Mar 2025
-
Type / Class
-
Equity / GENOMIC ADV ETF
-
Total 13F shares
-
81,687
-
Share change
-
-21,353
-
Total reported value
-
$2,205,710
-
Price per share
-
$27.00
-
Number of holders
-
8
-
Value change
-
-$638,047
-
Number of buys
-
7
-
Number of sells
-
3
Institutional Holders of FRANKLIN TEMPLETON ETF TR - GENOMIC ADV ETF (HELX) as of Q1 2025
As of 31 Mar 2025,
FRANKLIN TEMPLETON ETF TR - GENOMIC ADV ETF (HELX) was held by
8 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
81,687 shares.
The largest 8 holders included
CITADEL ADVISORS LLC, LPL Financial LLC, JANE STREET GROUP, LLC, UBS Group AG, OSAIC HOLDINGS, INC., HALBERT HARGROVE GLOBAL ADVISORS, LLC, HARBOUR INVESTMENTS, INC., and MORGAN STANLEY.
This page lists
8
institutional shareholders reporting positions in this security
for the Q1 2025 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.